184 related articles for article (PubMed ID: 22534472)
1. The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.
Nebes RD; Pollock BG; Perera S; Halligan EM; Saxton JA
Am J Geriatr Pharmacother; 2012 Jun; 10(3):185-92. PubMed ID: 22534472
[TBL] [Abstract][Full Text] [Related]
2. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
3. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
4. Increased mental slowing associated with the APOE epsilon4 allele after trihexyphenidyl oral anticholinergic challenge in healthy elderly.
Pomara N; Belzer K; Hernando R; De La Pena C; Sidtis JJ
Am J Geriatr Psychiatry; 2008 Feb; 16(2):116-24. PubMed ID: 18239197
[TBL] [Abstract][Full Text] [Related]
5. The cognitive effects of anticholinergic drugs on apolipoprotein ε4 carriers and noncarriers in the Wisconsin Registry for Alzheimer's Prevention study.
Collin BG; Raju D; Katsikas S
Neuropsychology; 2021 Feb; 35(2):220-231. PubMed ID: 33764112
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E Genotype Modifies the Association Between Cardiac Output and Cognition in Older Adults.
Bown CW; Liu D; Osborn KE; Gupta DK; Mendes LA; Pechman KR; Hohman TJ; Wang TJ; Gifford KA; Jefferson AL
J Am Heart Assoc; 2019 Aug; 8(15):e011146. PubMed ID: 31364446
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
8. APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging.
Quintino-Santos S; Diniz BS; Firmo JO; Moriguchi EH; Lima-Costa MF; Castro-Costa E
Int J Geriatr Psychiatry; 2015 Jun; 30(6):573-9. PubMed ID: 25132317
[TBL] [Abstract][Full Text] [Related]
9. Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction.
Feng L; Li J; Yap KB; Kua EH; Ng TP
Am J Clin Nutr; 2009 Apr; 89(4):1263-8. PubMed ID: 19244370
[TBL] [Abstract][Full Text] [Related]
10. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study.
Dore GA; Elias MF; Robbins MA; Elias PK; Nagy Z
Diabetologia; 2009 Dec; 52(12):2551-60. PubMed ID: 19693485
[TBL] [Abstract][Full Text] [Related]
11. ApoE and quality of life in nonagenarians.
Parsaik AK; Lapid MI; Rummans TA; Cha RH; Boeve BF; Pankratz VS; Tangalos EG; Petersen RC
J Am Med Dir Assoc; 2012 Oct; 13(8):704-7. PubMed ID: 22863665
[TBL] [Abstract][Full Text] [Related]
12. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.
Ma F; Wang J; Miao R; Zhao W; Wang Q
Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
14. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.
Thambisetty M; Beason-Held L; An Y; Kraut MA; Resnick SM
Arch Neurol; 2010 Jan; 67(1):93-8. PubMed ID: 20065135
[TBL] [Abstract][Full Text] [Related]
15. Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline.
Rajan KB; Wilson RS; Skarupski KA; Mendes de Leon CF; Evans DA
Psychosom Med; 2014 Feb; 76(2):101-8. PubMed ID: 24434953
[TBL] [Abstract][Full Text] [Related]
16. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
18. The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients.
Bour AM; Rasquin SM; Baars L; van Boxtel MP; Visser PJ; Limburg M; Verhey FR
Dement Geriatr Cogn Disord; 2010; 29(6):534-42. PubMed ID: 20606435
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.
Chapman BP; Benedict RHB; Lin F; Roy S; Porteinsson A; Szigeti K; Federoff H; Mapstone M
Int J Geriatr Psychiatry; 2018 Feb; 33(2):332-339. PubMed ID: 28612377
[TBL] [Abstract][Full Text] [Related]
20. Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study.
Pomara N; Willoughby LM; Wesnes K; Sidtis JJ
Neuropsychopharmacology; 2004 Feb; 29(2):403-9. PubMed ID: 14735126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
